Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure
In paracetamol-induced ALF patients, Phoxilium® was associated with reduced incidence of severe hypophosphataemia, hypophosphataemia burden, and need of phosphate supplementation. Larger studies are needed to further assess its impact on ALF patient outcomes.
Authors
- Rinaldo Bellomo (ORCID: https://orcid.org/0000-0002-1650-8939)
- Stephen Warrillow (ORCID: https://orcid.org/0000-0002-7240-4106)
- Caleb Fisher (ORCID: https://orcid.org/0000-0003-3336-3898)
- Ary Serpa Neto (ORCID: https://orcid.org/0000-0003-1520-9387)
- Gabriel Chan
- Ian Baldwin (ORCID: https://orcid.org/0000-0001-9173-4429)
- Anis Chaba (ORCID: https://orcid.org/0000-0003-2694-7051)
Institutions
- The University of Melbourne (AU)
- Hospital Israelita Albert Einstein (BR)
- Austin Hospital (AU)
- Australian and New Zealand Intensive Care Society (AU)
- Monash University (AU)
- RMIT University (AU)
Publication Details
- Journal
- Blood Purification
- Published
- 2025-09-20
- DOI
- https://doi.org/10.1159/000548502
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00